India has reached a milestone in cancer treatment with the first successful allogeneic CAR-T therapy at P. D. Hinduja Hospital, led by Dr. Vijay Patil. CAR-T therapy, such as NexCar-19 by ImmunoACT, promises greater accessibility and affordability. Ajay Hinduja highlights the role of public-private partnerships in advancing this innovative cancer treatment.
